Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma

Blood (2014) 123 (10): 1461–1469.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals